Replies to post #4184 on LadRx Corp (LADXD)

[n4807g]

I've been digging Albumin binding mechanism. The nano particle deliver mechanism isn't unheard off.

Well sure, but the method of deploying albumin binding is different in each drug. The method used in LADR is apparently inferior to the method used to produce Abraxane. If LADR was equal or superior CYTR would actually be a buyout candidate. I find one of the most amusing, and troubling, events in the sordid history of stock manipulation the CYTR awarding of 180K insider options the day before issuing the 12/11/13 PR that caused the share price to more than double in next two days.

If nothing else, CYTR management is consistent in their desire to enrich themselves at the expense of shareholders.